NYSE:NTRNutrien Stock Price, Forecast & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NTR shares have increased by 3.3% and is now trading at $33.05. View which stocks have been most impacted by Coronavirus.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 6 hold ratings, 15 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Nutrien.

Nutrien Ltd (NYSE:NTR) posted its quarterly earnings results on Wednesday, May, 6th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.08. The company earned $4.19 billion during the quarter, compared to analyst estimates of $3.44 billion. Nutrien had a net margin of 4.49% and a return on equity of 4.66%. The firm's revenue for the quarter was up 12.6% on a year-over-year basis. During the same period last year, the business posted $0.20 earnings per share. View Nutrien's earnings history.

Nutrien announced a quarterly dividend on Wednesday, May 6th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.45 per share on Friday, July 17th. This represents a $1.80 annualized dividend and a yield of 5.45%. The ex-dividend date of this dividend is Monday, June 29th. View Nutrien's dividend history.

Nutrien issued an update on its FY20 earnings guidance on Wednesday, May, 6th. The company provided earnings per share guidance of $1.50-2.10 for the period, compared to the Thomson Reuters consensus estimate of $2.00.

22 brokerages have issued 12 month target prices for Nutrien's shares. Their forecasts range from $36.00 to $70.00. On average, they anticipate Nutrien's share price to reach $49.30 in the next twelve months. This suggests a possible upside of 49.2% from the stock's current price. View analysts' price targets for Nutrien.

Press coverage about NTR stock has been trending somewhat negative this week, InfoTrie reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Nutrien earned a news sentiment score of -1.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Nutrien.

Nutrien saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 2,550,000 shares, a decline of 10.8% from the June 15th total of 2,860,000 shares. Based on an average daily volume of 1,640,000 shares, the days-to-cover ratio is presently 1.6 days. Currently, 0.5% of the company's shares are short sold. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include Scotts Miracle-Gro (SMG), CF Industries (CF), Mosaic (MOS), Nufarm (NUF), American Vanguard (AVD), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Eden Research (EDEN), Evogene (EVGN), Bion Environmental Technologies (BNET), China Green Agriculture (CGA) and Kiwa Bio-Tech Products Group (KWBT). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include General Electric (GE), Bank of America (BAC), Cimarex Energy (XEC), Johnson & Johnson (JNJ), Intel (INTC), AT&T (T), Exxon Mobil (XOM), Micron Technology (MU), Verizon Communications (VZ) and Pfizer (PFE).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Hexavest Inc. (0.07%), Envestnet Asset Management Inc. (0.03%), PM CAPITAL Ltd (0.03%), Addenda Capital Inc. (0.02%), Van Strum & Towne Inc. (0.00%) and Cardinal Capital Management Inc. (0.00%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Addenda Capital Inc., Envestnet Asset Management Inc., CENTRAL TRUST Co, and Van Strum & Towne Inc..

NTR stock was purchased by a variety of institutional investors in the last quarter, including PM CAPITAL Ltd, Reitz Capital Advisors LLC, Cardinal Capital Management Inc., and Carroll Financial Associates Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $33.05.

Nutrien has a market capitalization of $18.83 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]